On August 27th, Sanofi China confirmed that as a preventive measure, the company has decided to temporarily suspend the supply and sales of influenza vaccines in China. As an investor, the reporter contacted domestic influenza vaccine manufacturer Hualan Vaccine. When asked whether the company's influenza vaccine production capacity and batch issuance would accelerate after Sanofi suspended inoculation, the staff said that these are preliminary work. The company has already issued many batches of influenza vaccine and has started supplying the market. Some markets are able to administer the vaccine, and the company's production volume can meet market demand. (Pengpai News)